image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k |
|---|---|---|
4db2732eef4b8d962cebf218a5ecb13b48ee4bc3c57dfcf4ba194b6695a00a6d.png | complex | <table><tr><td></td><td colspan="4">Mean percentage density (95% confidence interval)<sup>a,b</sup></td></tr><tr><td>Chemical</td><td>Nondetected</td><td>Below median<sup>d</sup></td><td>Above median<sup>d</sup></td><td><i>P</i><sub>trend</sub><sup>c</sup></td></tr><tr><td></td><td><i>n </i>= 225</td><td><i>n </i>= 19<... |
952491fbe388a9568e1174ee38203ba059127841afb1dbb612212c780380ccfd.png | complex | <table><tr><td></td><td colspan="2">Intra-assay</td><td colspan="2">Inter-assay</td></tr><tr><td>Specimens</td><td>Mean (U/L)</td><td>CV (%)</td><td>Mean (U/L)</td><td>CV (%)</td></tr><tr><td>Low</td><td>40.3</td><td>2.00</td><td>33.4</td><td>2.60</td></tr><tr><td>Medium</td><td>160.0</td><td>2.27</td><td>130.0</td><td... |
9bc188d43376affc481c570d1e95486797329b381bf5b21c7d9299e91a6f97f2.png | complex | <table><tr><td></td><td colspan="2">Linear probability models</td><td colspan="2">Maximum likelihood proceduresb</td></tr><tr><td></td><td>OLS</td><td>2SLS</td><td>Probit</td><td>Bivariate probit</td></tr><tr><td>Land rental</td><td>0.365 (0.142) <sup>**</sup></td><td>0.135 (0.033) <sup>**</sup></td><td>0.277 (0.063) <... |
4ecf19a28aa2b6177f713f566120a30d7fb906382282acda7aa48e28f3736034.png | complex | <table><tr><td rowspan="2">Cpd.</td><td colspan="6">IC<sub>50</sub> (μM)</td></tr><tr><td>CDK5/p25</td><td>GSK3α/β</td><td>DYRK1A</td><td>DYRK2</td><td>CLK1</td><td>CLK2</td></tr><tr><td>3a</td><td>> 10</td><td>> 10</td><td>> 10</td><td>> 10</td><td>> 10</td><td>> 10</td></tr><tr><td>3b... |
b476f1cb658e644dc73037ffbfdc788bc6bc52fdf53f6c96192336ed08fbeb1a.png | simple | <table><tr><td>Variable</td><td><i>p</i>-Value</td><td>HR</td><td>95% CI</td></tr><tr><td>Intestinal type vs. others</td><td>0.0025</td><td>0.5156</td><td>0.3143–0.8457</td></tr><tr><td>HLR type vs. others</td><td><0.0001</td><td>2.6683</td><td>1.7298–4.1160</td></tr><tr><td>Stage I/II vs. III/IV</td><td... |
5b94c4282545c2c2a9ce060b70df53a1dbecaa25be46fb308037c22e6e4ad084.png | complex | <table><tr><td></td><td colspan="3">One visit</td><td colspan="3">Two or more visits</td></tr><tr><td>Characteristic</td><td>N</td><td>%</td><td>HIV prev.<i><sup>a</sup></i></td><td>N</td><td>%</td><td>HIV prev.<i><sup>a</sup></i></td></tr><tr><td>Total</td><td>94020</td><td></td><td>34.1</td><td>8865</td><td></td><td>... |
89c16945f49ca54e9610b0216b39bd4e4da81ddca717cd8ee3c382f20698bf1a.png | simple | <table><tr><td>Compound</td><td>Target</td><td>p-eIF2α</td><td>Disease model</td><td>Disease effect</td><td>References</td></tr><tr><td>Salubrinal</td><td>PPP1R15A(GADD34)-PP1c/PPP1R15B-PP1c</td><td>↑</td><td>ALS (SOD1G93A)Prion disease</td><td>Beneficialdetrimental</td><td>[7, 88][65]</td></tr><tr><td>Guana... |
22d5279155ec93335cfb86ed6a93e6f79cfbdb93e1a522b3c7c2d2daf8bd4ade.png | simple | <table><tr><td>Variable</td><td>Number</td><td>Weighted %<sup>a</sup></td></tr><tr><td>Total</td><td>677.0</td><td>100.0</td></tr><tr><td>Male</td><td>302.0</td><td>48.0</td></tr><tr><td>Age</td><td></td><td></td></tr><tr><td><i><=35 years</i></td><td>222.0</td><td>33.4</td></tr><tr><td><i>35 < years < =50</i>... |
e9888a4103a229f96b57cb86a33ed1374913b78f4f6cd1ff00a26806400892a5.png | simple | <table><tr><td>Hematological index </td><td>Formula </td></tr><tr><td>Mentzer index (MI) (1973)</td><td>MCV/RBC </td></tr><tr><td>RDWI (1987)</td><td>MCV × RDW/RBC</td></tr><tr><td>Shine and Lal (S and L) (1977)</td><td>MCV × MCV × MCH/100</td></tr><tr><td>Srivastava (1973)</td><td>MCH/RBC</td></tr><tr><... |
0b1169f1f2c5533a4519cd683e4adf9b2bd143398fff56bdf4012bbcf1e95bc8.png | simple | <table><tr><td>EXPREF</td><td>Total</td><td>N (case)</td><td>N (control)</td><td>Disease Case</td><td>Disease Control</td><td>Source</td><td>Detection Method</td><td>Reference</td></tr><tr><td>Exp25666440</td><td>23</td><td>11</td><td>12</td><td>naïve Fabry patients</td><td>ERT</td><td>urine</td><td>nanoLC-ESI-MS... |
c2a191389cf0470932d34ad7311088df5d893f0d4065ec5bb9bd926334449203.png | simple | <table><tr><td>Technique</td><td>Type</td><td>Comments</td><td>References</td></tr><tr><td>Specific gene promoter: indicator protein fusions [i.e. beta-glucuronidase (GUS) or fluorescent proteins]</td><td>1, B</td><td>Long lead times of >2 months to get stably expressed genes, homozygous gene expression, sequences o... |
ed95b1193ccbd4f7ce34fb94c6415746601222d68aec0202f48112053ff605c7.png | complex | <table><tr><td>Total sample</td><td colspan="5">Soda consumption categories</td></tr><tr><td><i>N</i> = 888</td><td>None (<i>n</i> = 501)</td><td>1 or less serv/wk. (<i>n</i> = 245)</td><td colspan="2">≥ 2 serv/wk. (<i>n</i> = 142)</td><td><i>Overall Groups P</i>-value</td></tr><tr><td colspan="6">Model 1:</td></... |
44ae74b5600fa47cb4f5ebbf1f83688864bc89525cf026197fc50a94ad79aa56.png | complex | <table><tr><td> </td><td>Breakfast eaters<sup>a</sup></td><td>Breakfast skippers<sup>b</sup></td><td><i>P</i> value<sup>c</sup></td></tr><tr><td><i>n</i>, %</td><td>4188, 90.4</td><td>443, 9.6</td><td> </td></tr><tr><td>Men, %</td><td>78.2</td><td>73.8</td><td>0.04</td></tr><tr><td>Age, year</td><td>47.8 (7.1)</td><td>... |
1692a9413c00940c4bc00958e0ca5312e8532d4e8d219118668b7f7a52243b0c.png | complex | <table><tr><td>Groups</td><td>N</td><td>Age</td><td>BMI</td><td>EBL</td><td>Duration</td><td>PreHGB</td><td>PreHCT</td><td>PostHGB</td><td>PostHCT</td></tr><tr><td>Group 1</td><td>42</td><td>24.69 ± 6.2</td><td>21.70 ± 3.8</td><td>680.95 ± 313.12</td><td>5:58 ± 1:19</td><td>12.94 ± 2.0</td><td>... |
e7523389201501d8e5e3320c404fd333d3adb29f248b5e6661b689c8a296b2bc.png | complex | <table><tr><td rowspan="2">Characteristics</td><td>NASH - HCC</td><td>Non-NASH - HCC</td><td rowspan="2">P</td></tr><tr><td>(n = 45)</td><td>(n = 1074)</td></tr><tr><td>Male gender*</td><td>35 (77.8)</td><td>888 (82.7)</td><td>0.820</td></tr><tr><td>Age at time of diagnosis<sup>#</sup></td><td>67.6 (46.6-89.9)</td><td>... |
17b0b2b767b3016d188ac3e424260999fdfe0326c96509060a09bd084416c079.png | simple | <table><tr><td>Recalled receiving information on:</td><td>CP<sup>a</sup>n=106n (%)</td><td>PE<sup>a</sup>n=619n (%)</td><td><i>p</i>-value</td></tr><tr><td>Appropriate amount of weight gain</td><td>89 (84.0)</td><td>473 (76.4)</td><td>0.085</td></tr><tr><td>Exercise or active living during pregnancy</td><td>83 (78.3)</... |
ba02770e2159d42c5e0793cdf3956b3b01103e7840cb651df9eafb523a9fe1ce.png | simple | <table><tr><td>Batch Code</td><td>Mean particle size(μm) mean ± SEM</td><td>% yield = (Practical yield / Theoretical yield) × 100</td><td>Drug Entrapment (%)</td><td>Drug Encapsulation Efficiency (%)</td></tr><tr><td>K1</td><td>290.54± 6.52</td><td>90</td><td>1.33</td><td>02.39</td></tr><tr><td>K2</... |
e70a0965aca63e5bef9e9dedf4b502b150d24e042d66c11224e53e533a33ee90.png | simple | <table><tr><td>Population</td><td>Sample</td><td>Average</td><td>Standard deviation</td><td>Percentile 25%</td><td>Percentile 50%</td><td>Percentile 75%</td></tr><tr><td>General population</td><td>4176</td><td>59.3125</td><td>30.99565</td><td>40</td><td>70</td><td>80</td></tr><tr><td>General population (men)</td><td>17... |
45bc18f85c71b74abd973b635fac8a802dd4b593fbadcdbb282e5c43b13b7dcb.png | complex | <table><tr><td rowspan="2">Spirometry variable</td><td rowspan="2">Puncture approach</td><td>T<sub>0</sub></td><td></td><td></td><td>T<sub>30</sub></td><td></td><td></td></tr><tr><td>Median (Q1, Q3)</td><td>Median difference<sub>anterior-posterior</sub> (95 % CI)</td><td><i>p</i>-value (two-sided)</td><td>Median (Q1, Q... |
3550ae2e0807a7c8e8bfc302f10bb939d35fbda1993be9ad109930fc14ebc0c1.png | simple | <table><tr><td>Activity</td><td>Annual average E (mSv/yr)</td><td>Radiation source</td></tr><tr><td>Natural background due to external exposure (cosmic rays; terrestrial radionuclides)</td><td>0.9 (0.4; 0.5)</td><td>Cosmic rays, terrestrial radionuclides</td></tr><tr><td>Natural background due to internal exposure (inh... |
19f5ad244144b7c3469fd698d6b3389a9804082b8d939c65a5babafd30d09bd8.png | simple | <table><tr><td>Negative Papers</td><td>Positive Papers</td><td>Paper Score</td></tr><tr><td>10</td><td>100</td><td>0.60</td></tr><tr><td>20</td><td>100</td><td>0.63</td></tr><tr><td>30</td><td>100</td><td>0.63</td></tr><tr><td>40</td><td>100</td><td>0.64</td></tr><tr><td>10</td><td>200</td><td>0.56</td></tr><tr><td>20<... |
43f534bae26dea69ba822d00ed3a60f88aff1ffc5c497402d9c6a6a412b25c05.png | complex | <table><tr><td rowspan="2">Feature</td><td colspan="4">Value</td></tr><tr><td><i>D. rotundata</i> (v0.1)</td><td><i>A. thaliana</i> (TAIR10)</td><td><i>B. distachyon</i> (v3.1)</td><td><i>O. sativa</i> (v7_JGI 323)</td></tr><tr><td>Total length (Mbp)</td><td>594.23</td><td>119.67</td><td>271.16</td><td>374.47</td></tr>... |
a04baeebd08700d4c39d877ea51861fadf91ba98bf0abde5dc804fed8e6da154.png | complex | <table><tr><td>Characteristics</td><td>Hazard Ratio (95% Confidence Interval)<sup>a</sup></td></tr><tr><td>Age (continuous)</td><td>1.01 (1.001–1.02)*</td></tr><tr><td>Sex, female (versus male)</td><td>1.05 (0.80–1.37)</td></tr><tr><td colspan="2">Charlson Comorbidity Index</td></tr><tr><td> 0</td><td>Refer... |
d81c0610c9e2748cf4e334d83f304ec9773b0c247d6de2b32b1356153410eb38.png | simple | <table><tr><td>Variable</td><td>G1 (n=15)</td><td>G2 (n=16)</td><td>G3 (n=16)</td><td>G4 (n=16)</td></tr><tr><td>25(OH)D (ng/mL)</td><td>14.0±3.3</td><td>19.5±2.3a</td><td>24.0±2.3b</td><td>36.7±7.7c</td></tr><tr><td>Age (years)</td><td>61.7±3.6</td><td>60.8±2.9</td><td>58.8±2.9</td><... |
6da1c6122361343dd61020338e6069bc445ddc8a6fa458bfcc3489dbee41d584.png | simple | <table><tr><td>Blood group</td><td>n (%)</td><td>5-year DFS (%)</td><td>5-year OS (%)</td></tr><tr><td>A</td><td>146 (37.4)</td><td>38.1</td><td>46.9</td></tr><tr><td>B</td><td>108 (27.7)</td><td>31.4</td><td>38.6</td></tr><tr><td>O</td><td>109 (27.9)</td><td>32.8</td><td>42.9</td></tr><tr><td>AB</td><td>27 (6.9)</td><... |
2d3432d5eb731337d4dbd0fdcc8f01904c22a0525102dfb8aafc52d78370492e.png | complex | <table><tr><td rowspan="2">Element</td><td rowspan="2">Extraction in H<sub>2</sub>O</td><td rowspan="2">Extraction in 0.1 mol L<sup>−1</sup>HCl</td><td rowspan="2">Extraction in DTPA–CaCl<sub>2</sub>–TEA</td><td colspan="4">Total contents</td></tr><tr><td>Copper mine environ (site 1)</td><td>Former ir... |
ad346c03cb06daa620938525d29e4458248552ef05fa6559c81788f04f6bc7eb.png | simple | <table><tr><td>Concept given to justify why brain death is death</td><td>Neurologist responses (n = 192) [n (%; 95% confidence interval)]</td><td>Neurologists who agreed the conceptual basis makes brain death equivalent to death (n = 133) [n (%; 95% confidence interval)]</td></tr><tr><td>Higher brain concept</td><td>63... |
040656651cc9d70b8a6d7cec880322c079ef3613e7bba61bbe2f7b1a5154d27c.png | simple | <table><tr><td>Sociocultural variables</td><td>C 1</td><td>C 2</td></tr><tr><td>NBI</td><td>0.103</td><td>-0.620</td></tr><tr><td>Tourism</td><td>-0.702</td><td>0.597</td></tr><tr><td>Food - Men</td><td>0.882</td><td>-0.096</td></tr><tr><td>Food - Women</td><td>0.798</td><td>0.357</td></tr><tr><td>Medicinal - Men</td><... |
1264997142de6e32fc431a7b3aa4632867cecedca10a1251fd2c2c0010569d13.png | complex | <table><tr><td>SNP</td><td>LVRS Response Phenotype</td><td colspan="2">All subjects(n = 203)</td><td colspan="2">Upper lobe, low exercise(n = 59)</td><td colspan="2">Upper lobe, high exercise(n = 84)</td><td colspan="2">Non-upper lobe, low exercise(n = 23)</td><td colspan="2">Non-upper lobe, high exercise(n = 37)</td><... |
7f1b4ebe06ab84438b34923b688287272b2bc626b50b5c3fe9c270c9bb73f940.png | complex | <table><tr><td colspan="2">Round 1</td></tr><tr><td rowspan="3">Communicating about symptoms and quality of life</td><td>(1) Tell us about a time when you told your doctor or nurse about a symptom that was bothering you—like trouble sleeping or being sick to your stomach. What was difficult or easy about this tim... |
6003349bafd3844b36a9345cf40f3edfaa9e76a093a25170a78c4556f5e26676.png | simple | <table><tr><td>Subjects</td><td>27</td></tr><tr><td>Sex</td><td>14 (51.8%) male</td></tr><tr><td>Age (years)</td><td>7.92 (±2.52)</td></tr><tr><td>Weight (kilograms)</td><td>34.89±14.89</td></tr><tr><td>Height (meters)</td><td>1.34±0.15</td></tr><tr><td>BMI (kg/m<sup>2</sup>), z-score</td><td>18.63±... |
85da8c5102bce7527906e98a3eac7646b0eda59842d3794f9fd3a1e1872c1117.png | simple | <table><tr><td>Gene</td><td>Forward primer (5′ to 3′)</td><td>Reverse primer (5′ to 3′)</td></tr><tr><td><i>MeCWINV1</i></td><td>CGCGGATCCAAAATAGAGATGGAAGCAAT</td><td>CGCGTCGACATCATTTCTCAAACATACCC</td></tr><tr><td><i>MeCWINV2</i></td><td>CATGCCATGGTCTTCTTCATCTTCAGTC</td><td>CGGGTTACCTTTTATCTTTAG... |
235e91e913853fa69bbbc93e2aa3e042b6d2e31f6ffc815f81f4d51383c9e848.png | complex | <table><tr><td></td><td>HRCT score</td><td colspan="5">MRI score</td></tr><tr><td></td><td></td><td>0</td><td>1</td><td>2</td><td>3</td><td>4</td></tr><tr><td>Consolidation</td><td>52</td><td></td><td></td><td></td><td></td><td>52</td></tr><tr><td>Alteration consistent with caseosis</td><td>undetermined</td><td></td><t... |
e369cdda5c954c3661e49456a195a91056d8de79bc7215caad5a1b7a542bdd34.png | simple | <table><tr><td>Time</td><td>Flow</td><td>%Phase C<sup>1</sup></td><td>%Phase A</td><td>Curve</td></tr><tr><td>0.0</td><td>0.20</td><td>10</td><td>90</td><td>6</td></tr><tr><td>1.0</td><td>0.20</td><td>10</td><td>90</td><td>6</td></tr><tr><td>40.0</td><td>0.20</td><td>100</td><td>0</td><td>6</td></tr><tr><td>45.0</td><t... |
941919aa0ea092ff7ef8e33a08d54c84e03f0792707dbb03d08af483cc1ee35f.png | simple | <table><tr><td>Term</td><td>Genes</td><td><i>p</i>-value</td></tr><tr><td>hsa05214:Glioma</td><td>CDKN1A, CDK6</td><td>0.018</td></tr><tr><td>hsa04115:p53 signaling pathway</td><td>CDKN1A, CDK6</td><td>0.019</td></tr><tr><td>hsa05218:Melanoma</td><td>CDKN1A, CDK6</td><td>0.02</td></tr><tr><td>hsa05220:Chronic myeloid l... |
ca15d81c56679a1085a46260a3764faff5b5612778b9ddeaccd21aba18fe915f.png | simple | <table><tr><td></td><td>Model 1</td><td>Model 2</td><td>Model 3</td><td>Model 4</td></tr><tr><td>Independence</td><td>1076</td><td>1076</td><td>717</td><td>279</td></tr><tr><td>Chi-square</td><td>(378 df)</td><td>(378 df)</td><td>(171)</td><td>(55 df)</td></tr><tr><td>Average standardised residuals</td><td>0.11</td><td... |
e014106f673018307bcd53170e3d50577f8d6709fd45feeddb0308a38bda87e0.png | simple | <table><tr><td></td><td><i>ρ</i> of TER</td><td><i>p</i> Value</td><td><i>ρ</i> of Delay Time</td><td><i>p</i> Value</td></tr><tr><td>upregulation</td><td>−0.084</td><td>0.43</td><td>0.37</td><td>2.7 × 10<sup>−4</sup></td></tr><tr><td>maximal FC</td><td>−0.17</td><td>0.10</td><td>0.416<... |
766df61b51582b88e2ce72799fb79fc7988044e2990e150ea17095b1355a1d23.png | simple | <table><tr><td>Themes</td><td>Categories</td><td>Definitions</td></tr><tr><td>Development of national maternal healthguidelines</td><td> · Development Process</td><td>· the steps taken to develop and produce guidelines</td></tr><tr><td></td><td> · Stakeholder participation</td><td>· level of involve... |
55e99b45a64fce0c2565e15229e77c6063a7b62e883884a85661e65868f19009.png | simple | <table><tr><td>Variables</td><td>Beta (OR)**</td><td>95% CI</td><td><i>P</i></td></tr><tr><td>Protein (g)</td><td>0.011</td><td>-0.04, 0.029</td><td>0.668</td></tr><tr><td>Carbohydrates (g)</td><td>0.129</td><td>0.012, 0.172</td><td>0.341</td></tr><tr><td>Iron (mg)</td><td>1.128</td><td>0.002, 0.161</td><td>0.031*</td>... |
c0d0ccc8f9310f2d67bafcc5b5f0bcefea69da14fde465037749b285fcfc720f.png | simple | <table><tr><td>Effect</td><td>Data structure</td><td>Type of test</td><td>Power</td><td>df (between)</td><td>df (within)</td><td><i>F</i></td><td>χ2</td><td><i>p</i></td></tr><tr><td>Pairwise discrimination phase (d)</td><td>Normally distributed</td><td>Two-factor repeated-measures ANOVA</td><td>0.96</td><td>1</td... |
05ba337f0dfd6ac724c6c63815e71c469d4702dbeb4be434bde6899df8df5f5b.png | simple | <table><tr><td>Authors/Year</td><td>Country</td><td>Design</td><td>Valable</td><td>OR (95% CI)</td></tr><tr><td>Chen 1995 [17]</td><td>England</td><td>Case–control</td><td>Severe life events</td><td>11.64 (3.10-43.66)</td></tr><tr><td>Protheroe 1999 [19]</td><td>Australia</td><td>Case–control</td><td>Severe... |
9710f6a7c1b82cecd07dc8af664c4974b7dfe1696dec4dd714c6cb6080d29397.png | simple | <table><tr><td></td><td>Grade 1</td><td>Grade 2</td><td>Grade 3</td><td>Grade 4</td><td>Grade 5</td></tr><tr><td>Pre CXL</td><td>0 (0 %)</td><td>0 (0 %)</td><td>3 (12.5 %)</td><td>8 (33.3%)</td><td>13 (64.2%)</td></tr><tr><td>Post CXL</td><td>16 (66.6%)</td><td>8 (33.3%)</td><td>0 (0%)</td><td>0 (0%)</td><td>0 (0%)</td... |
459c054e4a357b447708be7472a1003272d9fbc684de664166cb7f80d119d2d1.png | simple | <table><tr><td>Adverse reactions and treatment</td><td>Ketotifen</td><td>Placebo</td></tr><tr><td>Total no. of doses of OIT, n</td><td>36</td><td>18</td></tr><tr><td>Total no. of patients reporting symptoms</td><td>3/4</td><td>2/2</td></tr><tr><td>Total no. of doses with symptoms, n (% of total OIT doses)</td><td>8/36 ... |
f9f90bf0e6fed28537c56d6e1a50ff9fa69c8db17c91da2b7a8a4c3d8ef47496.png | simple | <table><tr><td>Linear range</td><td>R<sup>2</sup></td><td>LOD (μg/kg)</td><td>RSD (%)</td><td>Recovery (%)</td></tr><tr><td>20~200 μg/L</td><td>0.9988</td><td>2.4</td><td>3.5</td><td>91~97</td></tr></table> |
ee449812cc90b593153e5ed98f86d9a08ddbedfca5aabc7525066ec75f342bbd.png | simple | <table><tr><td></td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td></tr><tr><td>PTGI total score</td><td>1</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>PHQ-9 total score</td><td>0.12*</td><td>1</td><td></td><td></... |
dde787cafdea0674645424cc3316a9114c4fabbe56985ee0de4492222d4e662a.png | simple | <table><tr><td>Identified symptom</td><td>TotalN (%)</td><td>MaleN (%)</td><td>FemaleN (%)</td><td>X<sup>2</sup></td><td>p value</td></tr><tr><td>Fatigue</td><td>27 (9.8)</td><td>9 (6.3)</td><td>18 (13.6)</td><td>4.18*</td><td>0.041</td></tr><tr><td>Insomnia</td><td>47 (17.1)</td><td>23 (16.1)</td><td>24 (18.2)</td><td... |
b870dd57e310584855157a2c295b10de6cb35bda6cd7d4afd7f917a894650d88.png | simple | <table><tr><td>Parameters(mean ± SD)</td><td>GDM(<i>n</i> = 45)</td><td>Non-GDM(<i>n</i> = 45)</td><td><i>p</i> value</td></tr><tr><td>Age (years)</td><td>29.27 ± 6.87</td><td>26.84 ± 6.99</td><td>0.101</td></tr><tr><td>Weight (Kg)</td><td>72.84 ± 8.79</td><td>70.84 ± 8.39</td><td>0.273</td></t... |
f9328c5bfda60706d48dba6ea656a5ac59745bf9e94a0c901199fa35747342f1.png | simple | <table><tr><td>Explanatory variables</td><td>β<sup>a</sup></td><td>95% CI for β</td><td>P value</td></tr><tr><td>Waiting time</td><td></td><td></td><td></td></tr><tr><td> 0–3 months</td><td>Reference</td><td></td><td></td></tr><tr><td> > 3–6 months</td><td>0.013</td><td>-0.016, 0.043</td><td>0.... |
3e2825eca1b99179843c1b0c3ccaad9127d001f18b1590a6f36f6f7ee34dd901.png | complex | <table><tr><td>Condition</td><td>Test</td><td>Absolute error (95% CI)</td><td>Symptomatic diagnosis-Tariff method with health care experience absolute error (95% CI)</td></tr><tr><td rowspan="3">Asthma</td><td>World Health Survey (WHS): Doctor (MD) diagnosis (Dx) [34]</td><td>0.023 (0.020, 0.025)</td><td rowspan="3">0.... |
6472b6d43f7963d2fa7912f25cc6c9de0f63664fa1bc4fe5401ef9c28cbb0c55.png | complex | <table><tr><td></td><td>Topic</td></tr><tr><td colspan="2">Week 1</td></tr><tr><td>Day 1</td><td>An Overview of Maternal-Infant Care</td></tr><tr><td>Day 2</td><td>The Role of the Birth Attendant, Health Care Resources, and the Emergency Plan</td></tr><tr><td colspan="2">Week 2</td></tr><tr><td>Day 3</td><td>Sexual Org... |
1106daf0b16728b9db3451d61078675ee233450e53a6809aba9dac7f224484d0.png | complex | <table><tr><td colspan="5">Ergonomic problems</td></tr><tr><td>Categories</td><td>Working posture and type of examination</td><td>Equipment and physical factors</td><td>The patient’s physique and health</td><td>Work experience and knowledge</td></tr><tr><td>Subcategories</td><td>-Echocardiography-Vascular examina... |
c1041fe5722562603c9fc9598afe87c2f926265299ac5618e990aaf5d5338f63.png | complex | <table><tr><td>Variables</td><td>Chi Square</td><td>95% C.I.</td><td>Hazard Ratio</td><td><i>P </i>Value</td></tr><tr><td colspan="5">DFS</td></tr><tr><td>1. Cellular differentiation</td><td>10.51</td><td>4.20 – 463.30</td><td>0.3101</td><td>0.005*</td></tr><tr><td colspan="5">OS</td></tr><tr><td>1. Tumor Grade</... |
9e96320c11a1a2f3a7fbd325de7a3b8217b2bec31509eed83f99b59bc8b7e292.png | simple | <table><tr><td> </td><td>Number of people</td><td>Percentage (%)</td></tr><tr><td>Before preferences learning</td><td>3</td><td>7.65%</td></tr><tr><td>After preferences learning</td><td>14</td><td>82.35%</td></tr><tr><td>Total number of people and percentage</td><td>17</td><td>100%</td></tr></table> |
7e30cff0be3b9f6ca7d17aed4a25029f680a4773c85ee3789ebdbc81ea331438.png | simple | <table><tr><td></td><td>N</td><td>ATPIII 2001</td><td>ATPIII revised</td><td>WHO</td><td>IDF</td></tr><tr><td>NHANES 1988-1994 [143]</td><td>8,814</td><td>23.7%</td><td></td><td></td><td></td></tr><tr><td>NHANES 1988-1994 [144]</td><td>8,608</td><td>23.9%</td><td></td><td>25.1%</td><td></td></tr><tr><td>NHANES 1988-199... |
f3460f36d126a350f164d71d7acb162bba563956e491910ad497c44c85865473.png | complex | <table><tr><td rowspan="2"> </td><td>All</td><td>Group 1</td><td>Group 2</td><td>Group 3</td><td>Group 4</td><td><i>P </i>- values</td></tr><tr><td>(N = 203)</td><td>(N = 46)</td><td>(N = 64)</td><td>(N = 64)</td><td>(N = 29)</td><td> </td></tr><tr><td>Age (years)</td><td> </td><td> </td><td> </td><td> </td><td> </td><... |
ab357293b6b15b1078ab3761efc87e41954d79557d231ea5dd7a0a64c27136fd.png | simple | <table><tr><td></td><td></td><td>AOR single measure<sup>1</sup></td><td></td><td></td></tr><tr><td>Knowledge measure</td><td>Bivariate OR</td><td>Mozambique</td><td>4 Southern African countries<sup>2</sup></td><td>AOR all measures<sup>3</sup></td></tr><tr><td>Needles/razors</td><td>1.13 (0.70–1.83)</td><td>0.91 (... |
31cbdddf2f0eaac4cb2d03fc70b4b6ec110e77264bbf7ee1f6e28983e51e3326.png | complex | <table><tr><td rowspan="2"></td><td colspan="4">Stage</td></tr><tr><td>1</td><td>2</td><td>3</td><td><i>P</i> value</td></tr><tr><td>Number of patients</td><td>2</td><td>6</td><td>1</td><td></td></tr><tr><td>Location (%)</td><td></td><td></td><td></td><td>1</td></tr><tr><td> Mandible</td><td>2 (100)</td><td>5 (83.33)</... |
30e1b23119379ab9603aeea1269ad3285c5d0d0ca9bfce3e66d7dbe68817af04.png | complex | <table><tr><td rowspan="2" colspan="2">Virus</td><td colspan="3">% with HI titer ≥40</td></tr><tr><td>Serum wave 1 (n = 59)</td><td>Serum wave 2 (n = 32)</td><td>Serum wave 3 (n = 33)</td></tr><tr><td></td><td>CA/07</td><td>81.4 (48/59)</td><td>71.9 (23/32)</td><td>78.8 (26/33)</td></tr><tr><td rowspan="3">Thaila... |
b1997a1bc4e364362baa2c2c5c48cc8841eaf043ba1bbf9f9821e57be5f10b12.png | complex | <table><tr><td> </td><td>Patients (n)</td><td>HSR (n)</td><td>HSR (%)</td><td>p value<sup>1</sup></td></tr><tr><td>Sex</td><td> </td><td> </td><td> </td><td> </td></tr><tr><td>Female</td><td>113</td><td>16</td><td>14.2</td><td>0,0147</td></tr><tr><td>Male</td><td>78</td><td>1</td><td>1.3</td><td> </td></tr><tr><td cols... |
faca1be2d8cbc34424612dd6198c7e2e26e45ef58d3dfabbf382b95c23e53580.png | complex | <table><tr><td></td><td colspan="2">Oromia</td><td colspan="2">SNNP</td><td colspan="2">All</td></tr><tr><td></td><td colspan="2">n = 57</td><td colspan="2">n = 73</td><td colspan="2">n = 130</td></tr><tr><td></td><td>n</td><td>%</td><td>n</td><td>%</td><td>n</td><td>%</td></tr><tr><td>Training Received by HEWs<sup>a</... |
d4bf4fe361ddc57661f066cc679d7b6640a8801400588e36ee53fa0b6df0e81a.png | complex | <table><tr><td>Items</td><td>Mean age</td><td>Diagnosis</td><td>ACF</td><td>PIF + PD</td><td>One stage of ACF and PIF + PD</td></tr><tr><td rowspan="2">Present study</td><td rowspan="2">67.6 y/o</td><td rowspan="2">Degenerative cervical kyphosis with stenosis</td><td>ABL: 135.2 ± 85.2 ml</td><td>ABL: 307.7 ± ... |
0fa625e9884a765dc2c4e640a8de5bff69aa66d4aab50989f0e5711f935dd983.png | simple | <table><tr><td>Characteristic</td><td>Cluster 1 Most Severe (n = 30)</td><td>Cluster 2 Intermediate (n = 67)</td><td>Cluster 3 Least Severe (n = 67)</td></tr><tr><td> SF-36 Scales (mean ± sd)</td><td></td><td></td><td></td></tr><tr><td>Physical function</td><td>49.5 ± 21.8</td><td>71.8 ± 20.1</td><td>91.... |
f79e802b11e68cd2944d0cbd0dedbc4e3bfb2a76afd77d6ebcde50c0584cb615.png | simple | <table><tr><td>Class</td><td>Biophysical Features</td><td>Geographical Regions</td></tr><tr><td>1</td><td>lowest temperature and high chlorophyll a</td><td>south side of Bali, Sumbawa, Fores and Sumba</td></tr><tr><td>2</td><td>moderate biophysical conditions</td><td>Savu Sea (in the west) and Arafura Sea (in the east)... |
c8f95992c3936d437a38ca665bb893ef55e0a2019a0dcdf8592e7addcecf77af.png | simple | <table><tr><td>Scenario</td><td>WI ORCF</td><td>GA BRCF</td><td>GA ARCF</td><td>RA BRCF</td><td>RA ARCF</td><td>TA ORCF</td></tr><tr><td>1</td><td>29.2727</td><td>5.8364</td><td>6.3186</td><td>9.3091</td><td>9.3363</td><td>8.7455</td></tr><tr><td>2</td><td>109.3333</td><td>20.0000</td><td>23.7894</td><td>31.3333</td><t... |
fd4b775f5720e5e8d38ba125b9260179829b42e54c7b77ee6d677c5cff1a47ae.png | simple | <table><tr><td>Gene name</td><td>Primers</td><td>Annealing temperature</td></tr><tr><td><i>hHSF4F</i></td><td>CCCCCTCAAGAAAGTGTGGAA</td><td>60°C</td></tr><tr><td><i>hHSF4R</i></td><td>GAACCAAGGGCTGCATCAAG</td><td>60°C</td></tr><tr><td><i>mHSF4F</i></td><td>GGCACCAGCTTCCTCGTAAG</td><td>60°C</td></tr><tr><... |
ab2b67eda0b7f514c1badd784b5afc7eeeb4f467705913a9f4c91e816bfe4afb.png | complex | <table><tr><td>Animal models</td><td>Polyurethane scaffolds</td><td>Major conclusions</td><td>Reference</td></tr><tr><td rowspan="4">Iliac crest (sheep)</td><td rowspan="4">Porous scaffolds synthesized from HMDI, PEO-PPO-PEO, and PCL at various ratios. Pore size, 300 to 2,000 μm; porosity, 85%</td><td>At 18 and 25... |
0fd0d567d2b8cb6ccbbeef48460fe9ce242c20901862fac3103e2c74c2e87e1e.png | complex | <table><tr><td></td><td>SPATA2 7–219</td><td>HOIP 5–180 + SPATA2 334–344</td></tr><tr><td colspan="3">Data Collection</td></tr><tr><td>Beamline</td><td>Diamond I02</td><td>Diamond I02</td></tr><tr><td>Space group</td><td><i>P 2</i><sub><i>1</i></sub></td><td><i>P 4</i><sub><i>3</i></sub></td></tr><tr>... |
9d03a300d2ebf682c2bba45add3e91cbea4d7bebc604d92e4839175e850e34a7.png | complex | <table><tr><td>Sex and Age Groups</td><td colspan="3">Unintentional Injury Code</td><td colspan="3">Any Maltreatment Code</td></tr><tr><td> </td><td>Mean</td><td>SD</td><td>% with any risk documented</td><td>Mean</td><td>SD</td><td>% with any risk documented</td></tr><tr><td colspan="7">Males</td></tr><tr><td> <1</t... |
b9323303cdee95535cb5086a2960aef856c7245cbf23509a7c1a55f1a4a5d6ff.png | complex | <table><tr><td><i>Variables</i></td><td><i>All (</i>n<i>=704)</i></td><td><i>Presence of NHS-EMH (</i>n<i>=40)</i></td><td><i>Absence of NHS-EMH (</i>n<i>=664)</i></td><td>P<i>-value univariate</i></td><td>P-<i>value multivariate</i></td></tr><tr><td>Age at referall in years median (range)</td><td>64 (22–90)</td>... |
e4d55d4c6833837e6ed37f45ef3303ec789048893bc8fc9a8568e02accd03867.png | complex | <table><tr><td colspan="5">Central cardiologist</td></tr><tr><td> </td><td> </td><td>No RV dysfunction (n)</td><td>RV dysfunction (n)</td><td>Total (n)</td></tr><tr><td rowspan="3">Local cardiologist</td><td>No RV dysfunction (n)</td><td>55</td><td>4</td><td>59</td></tr><tr><td>RV dysfunction (n)</td><td>3</td><td>11</... |
3f667da1be81734c56bbf2165e36a43af02dbf8e2ada02ceebf6bf261d70e736.png | simple | <table><tr><td></td><td></td><td>Before peritonitis</td><td>12 hours peritonitis</td><td>18 hours peritonitis</td><td>24 hours peritonitis</td></tr><tr><td>Exhaled NO (pmol/kg/min)</td><td>Control</td><td>6 (3 to 47)</td><td>22 (6 to 72)<sup>b</sup></td><td>27 (11 to 98)<sup>b</sup></td><td>15 (14 to 141)<sup>b</sup></... |
b3ba653ab599848ea060c25c4ccacb7018c3576b915197de13da8728334923ad.png | complex | <table><tr><td>Label</td><td>Predicted function</td><td>Activity present in the following species</td><td>Activity suspected in <i>T. maritimum</i></td></tr><tr><td colspan="4">Iron uptake</td></tr><tr><td><i>MARIT_0169-0174</i></td><td>Siderophore biosynthesis system, Tbs</td><td>Deep sea metagenome (Fujita et al., 20... |
99b1c169700d82d43fb12bc9231eb896ebe74a5f6d76292af17fc25c8645c9e9.png | simple | <table><tr><td>Sample items</td><td>%Agree</td></tr><tr><td>I am worried that other people might realize that I am HIV + if they see me taking my HIV medications.</td><td>52</td></tr><tr><td>I get frustrated taking my HIV medications because I have to plan my life around them.</td><td>40</td></tr><tr><td>I don’t ... |
28ec9107447124a89e34ade5de90ee6277b5669cba567b93012c92f4bbf3b29f.png | simple | <table><tr><td>Smoking habit</td><td>Frequency among patients</td><td>Percentage</td><td>95% Confidence interval</td></tr><tr><td>No</td><td>106</td><td>77.9</td><td>70.1-84.2</td></tr><tr><td>Yes</td><td>27</td><td>19.9</td><td>13.9-27.5</td></tr><tr><td>Unknown</td><td>3</td><td>2.2</td><td>0.7-6.7</td></tr></table> |
ba0a2a75ba0bdd89d6e8e641bac4cfd2e9ff655808ab1dd79cdcb015f94b59eb.png | complex | <table><tr><td> </td><td> </td><td>No/minimal impairment(independent)</td><td>Moderate impairment(independent/unilateral support)</td><td>Severe impairment(bilateral support/wheelchair)</td><td><i>p</i> value</td></tr><tr><td colspan="6"><i>Peroneal nerve</i></td></tr><tr><td rowspan="2">Motor CV (m/sec)</td><td>CIDP</... |
ac664df4a5255b8ed1f70dbf9e25dc97bc9d48af6544e9c22fe0bd6395e1345b.png | simple | <table><tr><td></td><td>Mean (standard deviation)</td><td>Min value</td><td>Max value</td></tr><tr><td>CGI-S</td><td>4.16 (0.92)</td><td>2</td><td>6</td></tr><tr><td>PANSS total score</td><td>79.4 (16.34)</td><td>45</td><td>140</td></tr><tr><td>PANSS positive score</td><td>16.46 (5.15)</td><td>7</td><td>33</td></tr><tr... |
94e9e9c91cf85bbacd05931b858bde11aa3b600b5f074caa3fca73c5cf4b008e.png | complex | <table><tr><td rowspan="2">Features</td><td colspan="2">Patients</td></tr><tr><td><i>n</i></td><td>Frequency %</td></tr><tr><td>Gender</td><td> </td><td> </td></tr><tr><td> Males</td><td>344</td><td>82.3</td></tr><tr><td> Females</td><td>74</td><td>17.7</td></tr><tr><td>Age (years)</td><td> </td><td> </td></tr><tr><td>... |
32121112102c3f7cafea47345907f81a153be5af03be5f3e00f337df687661a9.png | complex | <table><tr><td rowspan="2">Groups</td><td colspan="2"> Ovarian weight</td></tr><tr><td>mg</td><td>mg/g body weight</td></tr><tr><td>Control</td><td>22.79 ± 4.87</td><td>1.26 ± 0.29</td></tr><tr><td>X-ray</td><td>12.54 ± 8.06<sup><i>∗∗</i></sup></td><td>0.71 ± 1.28<sup><i>∗∗</... |
5e1d8f29059794368c1c85389fbbcab52c51796982a99537345d3d853f46aefd.png | complex | <table><tr><td></td><td colspan="4">Final grade</td></tr><tr><td></td><td><i>Grade</i></td><td><i>1</i></td><td><i>2</i></td><td><i>3</i></td></tr><tr><td>Predicted grade</td><td><i>1</i></td><td>21</td><td>0</td><td>0</td></tr><tr><td></td><td><i>2</i></td><td>5</td><td>35</td><td>9</td></tr><tr><td></td><td><i>3</i><... |
8c6d9821d134328f74c2fd81450d9d92ac5bae9b8f67e78baf7fecf61f9a8b01.png | complex | <table><tr><td></td><td>Nurse/midwives <i>n</i> = 13</td><td>Doctors <i>n</i> = 05</td><td>Administrators <i>n</i> = 06</td></tr><tr><td colspan="4">Age (years)</td></tr><tr><td><30</td><td>6</td><td>1</td><td>0</td></tr><tr><td>30-39</td><td>3</td><td>3</td><td>0</td></tr><tr><td>40-49</td><td>2</td><td>0</td><td>1... |
36e64375e176789fb8260750dafb829a69d39921fcb7b29710d5e53ddd2349b7.png | complex | <table><tr><td rowspan="2"> </td><td colspan="2">Healthy sample</td><td colspan="2">Overall sample</td></tr><tr><td>male</td><td>female</td><td>male</td><td>female</td></tr><tr><td>N</td><td>342</td><td>859</td><td>1275</td><td>1577</td></tr><tr><td>Age , years</td><td>46.2 ± 15.4</td><td>46.7 ± 13.8</td><td>... |
5c41ce888c1d30040546b63e00f4595b28a34df720b08923cf519f22b4574fc9.png | complex | <table><tr><td>Transcript ID</td><td>LG</td><td>Start position</td><td colspan="4">Median reads per million (RPM) ± S.D.</td><td>Zebrafish homolog</td></tr><tr><td> </td><td> </td><td> </td><td>Pacific Ocean males</td><td>Pacific Ocean females</td><td>Japan Sea males</td><td>Japan Sea females</td><td> </td></tr><t... |
b6b1dda9f63506bdfcd29d581d654d6255fd958246786b0c92aba60411b7c2c6.png | complex | <table><tr><td></td><td colspan="3">If Rval<sup>a</sup> ≤ value</td><td colspan="3">If Rval ≥ value</td><td></td></tr><tr><td>Study</td><td>Value</td><td>Intercept 1</td><td>X1<sup>b</sup></td><td>Value</td><td>Intercept 2</td><td>X2<sup>b</sup></td><td>R<sup>2</sup></td></tr><tr><td> GNHIES98</td><td>73.26... |
234bf7b3f9dd44a5d2239e248bed2d4623cb0ea3c8ef92772ca6bd24525cd189.png | simple | <table><tr><td>Cardiovascular risk indicators</td><td>20 – 39 years</td><td>40 – 59 years</td><td>≥ 60 years</td><td>Total</td><td>p-value*</td></tr><tr><td>Total cholesterol (mg/dl)</td><td> </td><td> </td><td> </td><td> </td><td>0.871</td></tr><tr><td>Normal</td><td>238 (91.2)</td><td>100 (90.9)</td... |
eea66b442ad0487bf0d50db6e97047ec3ffa0a746340efd8d9abec89c2ad4b4c.png | simple | <table><tr><td></td><td>Total</td><td>N/100 orders</td><td>N/100 admissions</td><td>N/1000 patient-days</td></tr><tr><td>Orders</td><td>4942</td><td>NA*</td><td>7844</td><td>9709</td></tr><tr><td>Medication error</td><td>492</td><td>10</td><td>780</td><td>967</td></tr><tr><td>Adverse drug events</td><td>8</td><td>0.16<... |
1da2b821b08a1f15d814a01e671f3a74418a9ed4ffd49f3c27eda43a41283423.png | simple | <table><tr><td>Parameters</td><td>Value</td></tr><tr><td>Plant life</td><td>30 years</td></tr><tr><td>Discount rate</td><td>10%</td></tr><tr><td>Financing</td><td>40% equity</td></tr><tr><td>Loan terms</td><td>10-year loan at 8% APR</td></tr><tr><td>General plant depreciation</td><td>200% declining balance<sup>a</sup><... |
56a3681775c2a27cabc1227eae38c0cdd0a81337c76dafee09aac189c3a3843c.png | simple | <table><tr><td> Patient characteristics</td><td></td></tr><tr><td>Male/female</td><td>49 (63.6%)/28 (36.4%)</td></tr><tr><td>Birth weight (gr)</td><td>2930 ± 485 (range 4300-1800)</td></tr><tr><td>Gestational age at delivery (wk)</td><td>37 ± 2 (range 42–32)</td></tr><tr><td>Term/preterm delivery</td><t... |
2cae2be0109b44a20b8e593e4a5bff2855742867d65d9eb0e36b9c2e313d0aa7.png | simple | <table><tr><td>date (day of chth)</td><td></td><td></td></tr><tr><td>(I day)</td><td>1.</td><td>Doxorubicin 80 mg i.v.</td></tr><tr><td></td><td>2.</td><td>Cis-Platinium 40 mg i.v.</td></tr><tr><td></td><td>3.</td><td>5-FU 800 mg i.v.</td></tr><tr><td></td><td>4.</td><td>Roferon 9 MU</td></tr><tr><td>(II day)</td><td>1... |
37a43c46082c223b73773b6560852eb315fb041db7181d114b0885643d20a704.png | complex | <table><tr><td rowspan="2">Characteristics</td><td colspan="3">mRNA profiling</td><td colspan="3">microRNA profiling</td><td colspan="3">Total subjects</td></tr><tr><td>Trisomy 21 (<i>n</i> = 3)</td><td>Normal (<i>n</i> = 5)</td><td><i>P</i> value</td><td>Trisomy 21 (<i>n</i> = 4)</td><td>Normal (n = 5)</td><td><i>P</i... |
4bf136c9ae8c3fe0378c5838b25581081d8b352968e1ea87cd3f5db01f91d013.png | simple | <table><tr><td>Characteristics</td><td>Patients</td></tr><tr><td>Median age (y) (range)</td><td>52 (36–76)</td></tr><tr><td>Median parity (range)</td><td>3 (0–9)</td></tr><tr><td>Median BMI (range)</td><td>31.2 (21.4–41.5)</td></tr><tr><td>Prior surgery for prolapse including hysterectomy (<i>n</i>, %... |
6b60305e9446d2d8cc6c62b31b5cd3c94d75b5847f0995d15b38813d1f523415.png | simple | <table><tr><td>Sources of Attrition</td><td>N (%)</td><td>AA<sup>a</sup> (%)</td><td>EA<sup>a</sup> (%)</td><td><i>p</i>-value<sup>c,d</sup></td></tr><tr><td>Deceased</td><td>118 (26)</td><td>59 (50)</td><td>59 (50)</td><td>1.000</td></tr><tr><td>Frail</td><td>23 (5)</td><td>13 (57)</td><td>10 (44)</td><td>0.532</td></... |
1bdf5f2c05169f90689d19091ca0f54da1056cd9f90a2e8ab910ff93522e0b3a.png | complex | <table><tr><td rowspan="2"></td><td colspan="3">Univariate analysis</td><td colspan="3">Mulivariate analysis</td></tr><tr><td>β</td><td>95% CI</td><td>p</td><td>βadj</td><td>95% CI</td><td>p</td></tr><tr><td>Age of mother</td><td>−0.03</td><td>(− 0.08,0.02)</td><td>0.25</td><td>0.05</td><td>(0.03,... |
8532965a7f50f3df5219a5811299ab78afe171f2b262f033e834d3225e89534c.png | complex | <table><tr><td>Activities</td><td>Advantages</td><td>Specific challenges</td><td>Response</td></tr><tr><td rowspan="4">School meetings</td><td>• Easy to organize</td><td>• Low attendance</td><td>• Follow-up school meetings organized</td></tr><tr><td>• Resource and time efficient</td><td>• ... |
aa82c7e98f2c80e8d6df8b502ace41157b5e34c3106c0b3d4dbf6ef134081290.png | simple | <table><tr><td>Fluorescent real-time PCR</td><td>Orientation</td><td>Sequence<sup>a </sup>(5'---3')</td><td>Amplicon length (bp)</td></tr><tr><td>TaqMan</td><td>Sense</td><td>CCGCCTTTGAGTGAGCTGATA</td><td>210</td></tr><tr><td></td><td>Anti-sense</td><td>TGTAGACAACATCCCCTCCCC</td><td></td></tr><tr><td></td><td>Probe</td... |
32b3ea32eef47a265a857f7444f91ea7ed8702d0264003807be8b5c7c1141f85.png | complex | <table><tr><td colspan="10">Compounds</td></tr><tr><td>C</td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td></tr><tr><td>1</td><td>38.7</td><td>38.3<sup>a</sup></td><td>32.9</td><td>37.5</td><td>155.3</td><td>37.4</td><td>158.6</td><td>155.1</td><td>155.0</td></tr><tr><td>2</t... |
ffbb697875bdd85b7b287694a0b1765480a0bc7a9d23544d6f12927798a3cb36.png | complex | <table><tr><td rowspan="2">Variables</td><td colspan="3">Univariate analysis</td></tr><tr><td>HR</td><td>95% CI</td><td>P</td></tr><tr><td>Age (< 65 vs. ≥65)</td><td>1.47</td><td>0.68–3.17</td><td>NS</td></tr><tr><td>Gender (female vs. male)</td><td>0.74</td><td>0.29–1.84</td><td>NS</td></tr><tr><t... |
d83bc4a7a826ba888f76e21f831421dfa1e4fa5add94bd58993eede811eafcef.png | simple | <table><tr><td></td><td></td><td>HR (OS)</td><td>lower CI (95%)</td><td>upper CI (95%)</td><td><i>p</i>-value</td></tr><tr><td>Gender</td><td><i>male</i></td><td>1.000</td><td></td><td></td><td><i>0.026</i></td></tr><tr><td></td><td><i>female</i></td><td>0.518</td><td>0.290</td><td>0.925</td><td></td></tr><tr><td>Age</... |
20b1e4b02958a67d0a527bf67802df7dcc9f8860fce7127f76b20590e21cd54a.png | simple | <table><tr><td>Characteristics (Total <i>n</i> = 126)</td><td></td></tr><tr><td>Maternal</td><td></td></tr><tr><td>Age, year</td><td>32.8 ± 5.0</td></tr><tr><td>Ethnicity</td><td></td></tr><tr><td>European</td><td>104 (83%)</td></tr><tr><td>Maori</td><td>8 (6%)</td></tr><tr><td>Pacific</td><td>1 (1%)</td></tr><tr>... |
46ac0b0fd9a1a6dd4ca7bc05d300092b3e6022569b5ac5603d3104de156f5825.png | complex | <table><tr><td>Primer</td><td>Sequence (5' - 3')</td><td>Product size</td><td>Position in coding sequence</td><td>Reference</td></tr><tr><td>erm(A)-F</td><td>CCCGAAAAATACGCAAAATTTCAT</td><td>590</td><td>15-38</td><td>[23]</td></tr><tr><td>erm(A)-R</td><td>CCCTGTTTACCCATTTATAAACG</td><td></td><td>604-582</td><td></td></... |
43c5c1b168f38796d1e0eb2488a314b366873a759169d6ab5e39b1fc8358c050.png | complex | <table><tr><td> </td><td>theoretical</td><td colspan="2">measured</td></tr><tr><td> </td><td>mass content</td><td>mass content</td><td>molar composition</td></tr><tr><td>C</td><td>53.0 ± 0.9%</td><td>47.3 ± 0.1%</td><td>1</td></tr><tr><td>H</td><td>6.6 ± 0.1%</td><td>6.83 ± 0.04%</td><td>1.733</td><... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.